- Report
- April 2023
- 80 Pages
South Korea
From €1347EUR$1,500USD£1,147GBP
- Report
- April 2023
- 80 Pages
Saudi Arabia
From €1347EUR$1,500USD£1,147GBP
- Report
- April 2023
- 80 Pages
Russia
From €1347EUR$1,500USD£1,147GBP
- Report
- April 2023
- 80 Pages
Poland
From €1347EUR$1,500USD£1,147GBP
- Report
- April 2023
- 80 Pages
Japan
From €1347EUR$1,500USD£1,147GBP
- Report
- April 2023
- 80 Pages
Ireland
From €1347EUR$1,500USD£1,147GBP
- Report
- April 2023
- 80 Pages
India
From €1347EUR$1,500USD£1,147GBP
- Report
- April 2023
- 80 Pages
Germany
From €1347EUR$1,500USD£1,147GBP
- Report
- April 2023
- 80 Pages
France
From €1347EUR$1,500USD£1,147GBP
- Report
- April 2023
- 80 Pages
China
From €1347EUR$1,500USD£1,147GBP
- Report
- April 2023
- 80 Pages
Brazil
From €1347EUR$1,500USD£1,147GBP
- Report
- April 2023
- 80 Pages
Argentina
From €1347EUR$1,500USD£1,147GBP
- Report
- April 2023
- 180 Pages
Global
From €2245EUR$2,500USD£1,912GBP
- Report
- April 2023
- 100 Pages
Africa
From €1796EUR$2,000USD£1,529GBP
- Report
- January 2020
United States
From €874EUR$973USD£744GBP
€1248EUR$1,390USD£1,063GBP
- Report
- October 2023
- 74 Pages
Global
From €3500EUR$4,176USD£3,085GBP
- Report
- July 2023
- 90 Pages
Global
From €3500EUR$4,176USD£3,085GBP
- Report
- June 2023
- 123 Pages
Global
From €3500EUR$4,176USD£3,085GBP
- Report
- June 2023
- 105 Pages
Global
From €3500EUR$4,176USD£3,085GBP
- Report
- January 2024
- 86 Pages
Global
From €3500EUR$4,176USD£3,085GBP

Pneumonia is an infectious disease caused by bacteria, viruses, or fungi that affects the lungs. It is one of the most common infectious diseases and is a leading cause of death worldwide. Infectious disease testing is used to diagnose and monitor the progression of pneumonia. Tests used to diagnose pneumonia include chest X-rays, sputum cultures, and blood tests. Treatment for pneumonia typically involves antibiotics, antivirals, and other medications.
The pneumonia market within the context of infectious disease testing is a rapidly growing market. It is driven by the increasing prevalence of pneumonia, the development of new diagnostic technologies, and the increasing demand for rapid and accurate diagnosis. The market is expected to grow due to the increasing prevalence of pneumonia, the development of new diagnostic technologies, and the increasing demand for rapid and accurate diagnosis.
Some companies in the pneumonia market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, and Roche Diagnostics. Show Less Read more